No Data
Prospera Financial Services Inc Purchases New Stake in Zymeworks Inc. (NYSE:ZYME)
Prospera Financial Services Inc purchased a new stake in Zymeworks Inc. (NYSE:ZYME – Get Rating) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities a
Zymeworks Inc. CEO Ken Galbraith on Q2 2022 Results -- Earnings Call Transcript >ZYME
From Seeking Alpha: Zymeworks Inc. CEO Ken Galbraith on Q2 2022 Results -- Earnings Call Transcript
Zymeworks Names COO Neil Klompas as President
04:32 PM EDT, 08/05/2022 (MT Newswires) -- Zymeworks (ZYME) said late Friday that it has named Neil Klompas as president of the company, effective Aug. 4. Klompas joined the company in 2007 and is cu
Arizona State Retirement System Invests $89,000 in Zymeworks Inc. (NYSE:ZYME)
Arizona State Retirement System acquired a new position in shares of Zymeworks Inc. (NYSE:ZYME – Get Rating) during the first quarter, HoldingsChannel reports. The firm acquired 13,554 shares of the
Zymeworks Q2 EPS $(0.97) Misses $(0.96) Estimate, Sales $5.44M Miss $6.07M Estimate
Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate of $(0.96) by 1.04 percent. This is a 25.95 percent increase over losses of $(1.31) per
Press Release: Zymeworks Provides Corporate Update and Reports Second Quarter 2022 Financial Results
Zymeworks Provides Corporate Update and Reports Second Quarter 2022 Financial Results -- Zanidatamab zovodotin (ZW49) accepted for oral presentation of Phase 1 clinical data at European Soci
Zymeworks Non-GAAP EPS of -$0.92 beats by $0.02, revenue of $5.44M misses by $0.02M
Zymeworks press release (NYSE:ZYME): Q2 Non-GAAP EPS of -$0.92 beats by $0.02. Revenue of $5.44M (+207.3% Y/Y) misses by $0.02M.
Zymeworks reports Q2 EPS (97c), consensus (96c)
Reports Q2 revenue $5.44M, consensus $6.07M. "As we enter the second half of this year, we continue to advance towards delivering upon our stated goals for 2022 and look forward to reporting on progre
Press Release: Zymeworks Provides Corporate -3-
ZYMEWORKS INC. Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Expressed in thousands of U.S. dollars except share and per share data) (unaudited) Three
Earnings Flash (ZYME) ZYMEWORKS Reports Q2 Loss $-0.92
04:15 PM EDT, 08/04/2022 (MT Newswires) --
Loading...